Paclitaxel/Carboplatin With or Without Cetuximab in CUP
Status:
Unknown status
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an addition of cetuximab to
carboplatin/paclitaxel can improve efficacy in comparison to carboplatin/paclitaxel in
patients with carcinoma of unknown-primary.